ArticleWorld journal of gastroenterology2010
Steatosis and steatohepatitis in postmortem material from Northwestern Greece.
Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Article
- Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping.World journal of gastrointestinal pathophysiology · 2024Review
- The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.JMIR public health and surveillance · 2022Article
- High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor?Diagnostics (Basel, Switzerland) · 2021Article
- Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019Review
- Steatosis and steatohepatitis found in adults after death due to non-burn trauma.Clinics (Sao Paulo, Brazil) · 2019Article
- A systematic review of the present and future of non-alcoholic fatty liver disease.Clinical and experimental hepatology · 2018Review
- Fatty Liver and the Forensic Pathologist.Academic forensic pathology · 2018Review
- Article
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Nature reviews. Gastroenterology & hepatology · 2018Review
- Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.PloS one · 2017Article
- Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.Digestive diseases and sciences · 2016Review
- Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Clinical medicine insights. Therapeutics · 2016Article
- Role of liver biopsy in nonalcoholic fatty liver disease.World journal of gastroenterology · 2014Review
- Steatosis and steatohepatitis: complex disorders.International journal of molecular sciences · 2014Review
- The interaction of rs738409, obesity, and alcohol: a population-based autopsy study.The American journal of gastroenterology · 2012Article
- The changing epidemiology of hepatocellular carcinoma in Greece.Annals of gastroenterologyArticle
- Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis.Journal of clinical & experimental cardiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo determine the prevalence of steatosis and steatohepatitis in a series of autopsies in Northwestern Greece.
methodsLiver biopsy material from a total of 600 autopsies performed over a period of 2 years (2006-2008) to define the cause of death was subjected to histological examination. Patient demographic data were also collected. Tissue sections were stained with different dyes for the evaluation of liver architecture, degree of fibrosis and other pathological conditions when necessary.
resultsSatisfactory tissue samples for histological evaluation were available in 498 cases (341 male, 157 female) with a mean age of 64.51 +/- 17.78 years. In total, 144 (28.9%) had normal liver histology, 156 (31.3%) had evidence of steatosis, and 198 (39.8%) had typical histological findings of steatohepatitis. The most common causes of death were ischemic heart disease with or without myocardial infarction (43.4%), and traffic accidents (13.4%).
conclusionA high prevalence of steatosis and steatohepatitis was detected in postmortem biopsies from Northwestern Greece. Since both diseases can have serious clinical consequences, they should be considered as an important threat to the health of the general population in Greece.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.